Biomarker ID | 1418 |
PMID | 24741114 |
Year | 2014 |
Biomarker | PTK7 |
Biomarker Basis | Expression Based |
Biomolecule | Protein |
Source | Tissue |
Subjects | Humans |
Regulation | Upregulated in GS >7 |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways include: ALPK2 human kinase ARCHS4 coexpression, EIF2AK4 human kinase ARCHS4 coexpression, TRIO human kinase ARCHS4 coexpression, RYK human kinase ARCHS4 coexpression, DDR2 human kinase ARCHS4 coexpression |
Experiment | Gleason Score ≤ 7 and Gleason Score >7 |
Type of Biomarker | Prognostic |
Cohort | TMA analysis was performed with 56 prostate adenocarcinoma cases. Each case contained four cores of tumor and two cores of patient-matched adjacent normal tissue. |
Senstivity | NA |
Specificity | NA |
AUC | 0.709 |
Accuracy | NA |
Level Of Significance | p <0.01 |
Method Used | Immunohistochemistry |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on independent patient dataset |
Technical Name | NA |